LSO 2017 Annual Awards Gala Dinner
Wednesday, March 1st, 2017
2017 LSO Award Gala Highlights
2017 LSO Award Recipients
LIFETIME ACHIEVEMENT AWARD - Mickey Milner, Past President & CEO, HTX
Morris (Mickey) Milner, born and educated in Johannesburg, South Africa received B.Sc.(Eng) and Ph.D. degrees, respectively in 1957 and 1968, in the Department of Electrical Engineering, University of the Witwatersrand. He served there as a faculty member for over a decade, and initiated a program of biomedical engineering research. He subsequently held appointments at the National Research Council, Ottawa, University of Cape Town and Groote Schuur Hospital (as first Director of Bioengineering and Medical Physics), Emory University and Georgia Tech., Atlanta, Georgia, USA, and McMaster University, Hamilton, Ontario before joining the Ontario Crippled Childrens Centre) (now Holland Bloorview Kids Rehab Hospital) in 1978 as Director of Rehabilitation Engineering, then VP Research, with academic appointments at the University of Toronto in the Departments of Mechanical and Industrial Engineering, Rehabilitation Science, Surgery, and the Institute of Biomaterials and Biomedical Engineering (IBBME). He served as Deputy Director IBBME and Chairman, Rehabilitation Medicine. He is now Professor Emeritus in IBBME. He is Founding Director of the Ontario Rehabilitation Technology Consortium (ORTC) which linked Ontario rehabilitation facilities, academic centres, consumers, and manufacturers to develop and commercialize assistive technologies. Over 12 years of his participation, 33 ORTC assistive devices were marketed and some 10 start-ups initiated. He served as President and CEO, htx The Health Technology Exchange (HTX), then as Consultant to the organization and was a member of the Board of Directors. He was instrumental in attracting an investment of $21.4-million for the benefit of the medical and assistive technology sector in Ontario. He is currently a consultant in medical and assistive technologies. In 2015 he served on the project team for the Accessibility Innovation Showcase sponsored by the Ontario Government held alongside the ParaPan AM Games in August of that year.
COMMUNITY SERVICE AWARD - Rafi Hofstein, President & CEO, MaRS Innovation
Dr. Raphael (Rafi) Hofstein joined MaRS Innovation as President and CEO in June 2009. Dr. Hofstein received his PhD and Master of Science degrees in Life Sciences and Chemistry from the Weizmann Institute of Science in Rehovot, Israel. His Bachelor of Science degree in Chemistry and Physics from the Hebrew University in Jerusalem. Awards he received while completing post-doctoral training and research at the Harvard Medical School in Boston in the Departments of Biological Chemistry and Neurobiology include the Hereditary Disease Foundation Fellowship in 1982-83, and the Chaim Weizmann Postdoctoral Fellowship in 1980-82. During the 1980s, he held the roles of scientific director of Biotechnological Applications Ltd., and manager R&D and chief of Immunochemistry at the International Genetic Scientific Partnership, organizations that were pivotal in developing Israels world-leading biotechnology sector. Dr. Hofstein was scientific director of the Israeli office of Ecogen Inc., a subsidiary of Monsanto, for over six years before assuming the role of vice-president, Business Development for Ecogen in Langhorne, Pa. From 1997 to 1999 Dr. Hofstein was a venture partner at Medica Ventures, a leading medical technologies VC in Israel. Dr. Hofstein was the founder and served as chair of Hadasit BioHolding Ltd., a publicly-traded holding company (10 start-ups under management) on the Tel Aviv Stock Exchange (TASE) since 2005. Other directorships held on TASE publicly-traded companies include: Bioline RX (drug development); Exalenz (medical devices); and Evogene (agri-bio). He has also served as chairman of BIOMED, Israels annual biomedical conference, from 2005 to 2007. In addition, Dr. Hofstein is a co-founder and board member of ILSI, the Israeli Life Science Industry Organization, and a co-founder and executive in Israels Tech Transfer Network (ITTN). Dr. Hofstein is currently member of the board of directors of Life Science Ontario and of Clinical Trials Ontario as well as a member of the Organizing Committee of the Public Policy Forum on Venture Capital and Innovation (part of the Quebec City Conference).
LSO VOLUNTEER AWARD - Alison Symington, Principal, Life Science Strategic Consulting
Dr. Alison Symington provides consultancy services to a variety of industry and academic clients in the area of Life Science strategy, including proposal development and particularly at the interface of academia and industry. Previously Alison was the Vice President, Research and Corporate Development at Ontario Genomics where she was responsible for the development and management of large scale genomics projects as well as external stakeholder engagement. Prior to joining OGI, Alison was Executive Director of Biotechnology Education Canada (BEC), where she led the organization through a substantive rebranding and refocusing, and sponsored a number of events that created national impact in Canada and international visibility for Canadian science education.
LIFE SCIENCES COMPANY OF THE YEAR - Synaptive Medical represented by Cameron Piron, President and Co-founder
Synaptive is a medical device and technology company made up of a talented team of scientists, engineers, locally-based customer care specialists and business experts. In collaboration with leading clinicians and healthcare systems, Synaptive is revolutionizing products and services that cross traditional barriers to enable continuous improvement in care delivery, in and beyond the operating room. Their integrated BrightMatter solutions, including surgical planning, navigation and visualization, and informatics platform, are designed to give clinicians the information they need to ensure the best possible outcomes for patients.
LIFE SCIENCES LEADERSHIP AWARD - Russell Williams, Vice President Government Relations and Public Policy, Canadian Diabetes Association
As CDAs Vice President, Government Relations and Public Policy, Russell advises, shapes, develops, executes, and delivers on strategic priorities with regard to policy development, government relations, and advocacy. He proactively addresses local and nation-wide issues relevant to diabetes; creates networks and alliances; and builds positive relationships, both internally and externally, including government representatives, policy makers, and other stakeholders. Russells aim is to effectively communicate and advance CDAs interests and influence political and government agendas toward positive outcomes for Canadians living with and at risk of diabetes and prediabetes. Russell Williams was the former President of Innovative Medicines Canada (formerly Rx&D), an association of over 50 innovative life sciences companies. During his time there, he was involved in numerous provincial task forces on pharmaceutical policy, he worked directly with key government agencies, and he participated in a number of key coalitions focused on improving research, healthcare, and ethics networks. Prior to his appointment as President of Rx&D, he acted as the Member of the National Assembly for the riding of Nelligan in Montreal, and advocated for many causes, including better patient care, improved emergency services, increased research and development, individual rights, as well as reform for handicapped services.
. Thanks you to our Sponsors
2016 LSO Award Gala Highlights
2016 Award Recipients:
Murray McLaughlin – Lifetime Achievement Award
2015 LSO Award Gala Highlights
2015 Award Recipients:
John Oliver – Lifetime Achievement Award
2014 LSO Award Gala Highlights
2014 Award Recipients:
Mark Lievonen – Lifetime Achievement Award
2013 LSO Award Gala Highlights
In case you missed the LSO Awards Gala, videos of our award winners have been posted to our YouTube Channel
2013 Award Recipients:
Mark Poznansky – Lifetime Achievement Award